Wednesday, November 5, 2025
Home Authors Posts by Ogkologos

Ogkologos

4054 POSTS 0 COMMENTS

Inaugural ESMO Targeted Anticancer Therapies Asia Congress 2025, Hong Kong SAR,...

Ogkologos -
0

Encouraging Antitumour Activity of First-Line Atezolizumab Plus Paclitaxel and Bevacizumab in...

Ogkologos -
0

Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell...

Ogkologos -
0

Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab...

Ogkologos -
0

FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell...

Ogkologos -
0

EMA Recommends Extension of Indications for Cabozantinib

Ogkologos -
0

Switching to Camizestrant While Continuing a CDK4/6 Inhibitor After ESR1 Mutation...

Ogkologos -
0

Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for...

Ogkologos -
0

Adding Neoadjuvant and Adjuvant Pembrolizumab to Standard Care Significantly Improves EFS...

Ogkologos -
0

ESMO Welcomes the European Commission’s Life Sciences Strategy: A Vital Step...

Ogkologos -
0
1...101112...406Page 11 of 406

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com